1. Testoni PA, Mariani A, Giussani A, et al. Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study. Am J Gastroenterol. 2010;105:1753-1761.
2. Cotton PB, Garrow DA, Gallagher J, et al. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc. 2009;70:80-88.
3. Cheng CL, Sherman S, Watkins JL, et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol. 2006;101:139-147.
4. Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383-393.
5. Tryliskyy Y, Bryce GJ. Post-ERCP pancreatitis: Pathophysiology, early identification and risk stratification. Adv Clin Exp Med. 2018;27:149-154.
6. Takenaka M, Fujita T, Sugiyama D, et al. What is the most adapted indication of prophylactic pancreatic duct stent within the high-risk group of post-endoscopic retrograde cholangiopancreatography pancreatitis? Using the propensity score analysis. J Hepatobiliary Pancreat Sci. 2014;21:275-280.
7. Inatomi O, Bamba S, Nakai Y, et al. Diagnostic value of serum amylase levels indicating computed tomography-defined post-endoscopic retrograde cholangiopancreatography pancreatitis: A prospective multicenter observational study. Pancreas. 2020;49:957-959.
8. Yoon J, Kim KG, Kim YJ, et al. Distribution and characteristics of pancreatic volume using computed tomography volumetry. Healthc Inform Res. 2020;26:321-327.
9. Saisho Y. Pancreas volume and fat deposition in diabetes and normal physiology: consideration of the interplay between endocrine and exocrine pancreas. Rev Diabet Stud. 2016;13:132-147.
10. Miyamoto R, Oshiro Y, Sano N, et al. Remnant pancreatic volume as an indicator of poor prognosis in pancreatic cancer patients after resection. Pancreatology. 2019;19:716- 721.
11. Hirata K, Nakata B, Amano R, et al. Predictive factors for change of diabetes mellitus status after pancreatectomy in preoperative diabetic and nondiabetic patients. J Gastrointest Surg. 2014;18:1597-1603.
12. Maruyama H, Shiba M, Ishikawa‐ Kakiya Y, et al. Positive correlation between pancreatic volume and post‐ endoscopic retrograde cholangiopancreatography pancreatitis. J Gastroenterol Hepatol. 2019;35:769-776.
13. Agostini A, Borgheresi A, Bruno F, et al. New advances in CT imaging of pancreas diseases: a narrative review. Gland Surg. 2020;9:2283-2294.
14. Hong W, Ha HI, Lee JW, et al. Measurement of pancreatic fat fraction by CT histogram analysis to predict pancreatic fistula after pancreaticoduodenectomy. Korean J Radiol. Apr 2019;20:599-608.
15. Fujisawa T, Kagawa K, Hisatomi K, et al. Obesity with abundant subcutaneous adipose tissue increases the risk of post-ERCP pancreatitis. J Gastroenterol. Sep 2016;51:931-938.
16. Woods RW, Akshintala VS, Singh VK, et al. CT severity of post-ERCP pancreatitis: results from a single tertiary medical center. Abdom Imaging. 2014;39:1162-1168.
17. Green FL FA, Shah JP, Winchester DP, et al. ed. Exocrine pancreas. AJCC Cancer Staging Atlas. New York, NY: Springer; 2006:155-156.
18. Djuric-Stefanovic A, Masulovic D, et al. CT volumetry of normal pancreas: correlation with the pancreatic diameters measurable by the cross-sectional imaging, and relationship with the gender, age, and body constitution. Surg Radiol Anat. 2012;34:811- 817.
19. Owens WD, Felts JA, Spitznagel EL. ASA physical status classifications: a study of consistency of ratings. Anesthesiology. 1978;49:239-243.
20. Polack EP, Fainsinger MH, Bonnano SV. A death following complications of roentgenologic nonoperative manipulation of common bile duct calculi. Radiology. 1977;123:585-586.
21. Shirakawa S, Matsumoto I, Toyama H, et al. Pancreatic volumetric assessment as a predictor of new-onset diabetes following distal pancreatectomy. J Gastrointest Surg. 2012;16:2212-2219.
22. Umemura A, Sasaki A, Nitta H, et al. Pancreas volume reduction and metabolic effects in Japanese patients with severe obesity following laparoscopic sleeve gastrectomy. Endocr J. 2017;64:487-498.
23. Lim HK, Ha HI, Park SY, et al. Comparison of the diagnostic performance of CT Hounsfield unit histogram analysis and dual-energy X-ray absorptiometry in predicting osteoporosis of the femur. Eur Radiol. 2019;29:1831-1840.
24. Zhao ZH, Hu LH, Ren HB, et al. Incidence and risk factors for post-ERCP pancreatitis in chronic pancreatitis. Gastrointest Endosc. 2017;86:519-524.
25. Dumonceau JM, Kapral C, Aabakken L, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2020;52:127-149.
26. Acharya C, Cline RA, Jaligama D, et al. Fibrosis reduces severity of acute-on-chronic pancreatitis in humans. Gastroenterology. 2013;145:466-475.
27. Fasshauer M, Bluher M. Adipokines in health and disease. Trends Pharmacol Sci. Jul 2015;36:461-470.
28. Kwon H, Pessin JE. Adipokines mediate inflammation and insulin resistance. Front Endocrinol (Lausanne). 2013;4:71.
29. Mathur A, Marine M, Lu D, et al. Nonalcoholic fatty pancreas disease. HPB (Oxford). 2007;9:312-318.
30. Matsumoto S, Mori H, Miyake H, et al. Uneven fatty replacement of the pancreas: evaluation with CT. Radiology. 1995;194:453-458.
31. Ang TL. Mitigating the risk of post-ERCP pancreatitis: Science and clinical practice. J Gastroenterol Hepatol. 2020;35:703-704.